2967-72-8

Basic information

• Product Name: 3-(2-FLUORO-PHENOXY)-PROPIONIC ACID
• Synonyms: Propionicacid, 3-(o-fluorophenoxy)- (6CI,8CI);3-(2-Fluorophenoxy)propanoic acid;3-(2-Fluorophenoxy)propionic acid
• CAS NO: 2967-72-8
• Molecular Formula: C₉H₉FO₃
• Molecular Weight: 184.17
• Mol File: 2967-72-8.mol
• Article Data: 10

Chemical Properties

• Melting Point: 109-111 °C
• Boiling Point: 282.5 °C at 760 mmHg
• Flash Point: 124.6 °C
• Appearance: /
• Density: 1.267 g/cm³
• Vapor Pressure: 0.00158mmHg at 25°C
• Refractive Index: 1.514
• Storage Temp.: 2-8°C
• PKA: 4.13±0.10(Predicted)
• CAS DataBase Reference: 3-(2-FLUORO-PHENOXY)-PROPIONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(2-FLUORO-PHENOXY)-PROPIONIC ACID(2967-72-8)
• EPA Substance Registry System: 3-(2-FLUORO-PHENOXY)-PROPIONIC ACID(2967-72-8)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 2967-72-8(Hazardous Substances Data)

Usage

General Description

3-(2-Fluoro-Phenoxy)-Propionic Acid is a chemical compound that belongs to the class of organic compounds known as phenylpropanoic acids. It has a Fluoro-Phenoxy group attached to a propionic acid structure. Its molecular formula is C9H9FO3. The detailed properties and characteristics such as its solubility, stability, reactivity, toxicity, etc., are not widely documented and remain unclear as of now. This chemical may be potentially used in various fields including scientific research, manufacturing, and potentially within the pharmaceutical industry, based upon its structural characteristics. More research is, however, required to explore its potential applications and hazards.

InChI:InChI=1/C9H9FO3/c10-7-3-1-2-4-8(7)13-6-5-9(11)12/h1-4H,5-6H2,(H,11,12)

Upstream product

• 145073-40-1 3-(2-fluorophenoxy)-1-propanol 
• 367-12-4 2-fluorophenol 
• 57-57-8 β-Propiolactone 
• 590-92-1 3-Bromopropionic acid 
• 111140-91-1 3-(2-fluorophenoxy)propanenitrile 

Downstream Products

• 911826-26-1 (R)-2-(2-(2,4-dimethoxybenzylamino)-4-fluorophenylamino)-9-(8-fluorochroman-4-yl)-7H-purin-8(9H)-one 
• 911826-25-0 (R)-N₂-(2-(2,4-dimethoxybenzylamino)-4-fluorophenyl)-N₄-(8-fluorochroman-4-yl)-5-nitropyrimidine-2,4-diamine 
• 1026790-40-8 (R)-N₂-(2-(2,4-dimethoxybenzylamino)-4-fluorophenyl)-N₄-(8-fluorochroman-4-yl)pyrimidine-2,4,5-triamine 
• 1026790-41-9 (R)-2-(2-amino-4-fluorophenylamino)-9-(8-fluorochroman-4-yl)-7H-purin-8(9H)-one 
• 1003887-62-4 (S)-8-fluorochroman-4-amine 
• 791043-28-2 8-fluorochroman-4-amine 
• 750571-31-4 (R)-8-fluorochroman-4-amine 
• 245127-15-5 methyl 3-(2-fluorophenoxy)propanoate 
• 1392286-18-8 4-(2-fluorophenoxy)-2-methylbutan-2-ol 
• 1392286-17-7 4-(5-(8-fluoro-4,4-dimethylchroman-6-yl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide 
• 111141-00-5 8-fluoro-2,3-dihydro-4-H-1-benzopyran-4-one 
• 188826-32-6 5-fluoro-2,3-dihydro-4H-chromen-4-one 

Relevant articles and documents

Condensed derivatives of imidazole useful as pharmaceuticals

The invention relates to the compounds (I) and their acids and bases salts: wherein: the dotted line indicates a double bond; X is N or C-R1 and Y is N or C-R2, X and Y not being simultaneously N; A is selected from the group consisting of phenyl, naphthyl and (5-11) membered monocyclic or bicyclic unsaturated cycle or heterocycle possibly substituted as defined in the application, and A can also comprise either a further (4-7) membered heterocycle, said heterocycle being a monocycle, fused, saturated or unsaturated, the polycyclic system then comprising up to 14 members and up to 5 heteroatoms selected from N, O and S; B is Hydrogen or a substituent as defined in the application, or B is a (4-10) membered mono or bicyclic saturated or unsaturated heterocycle containing 1-3 heteroatoms selected from N, O and S, and possibly substituted as defined in the application; B not being Hydrogen when X is N and Y is C-R2; R1 is Hydrogen or a substituent as defined in the application; B and R1 cannot be simultaneously Hydrogen; R2 is Hydrogen or Halogen; their preparation, their use in the antibacterial prevention and therapy, alone or in association with antibacterials, antivirulence agents or drugs reinforcing the host innate immunity, and pharmaceutical compositions and associations containing them.

SPIROAMINODIHYDROTHIAZINE DERIVATIVES

A compound represented by the general formula (I): or a pharmaceutically acceptable salt thereof, has an Aβ production inhibitory effect or a BACE1 inhibitory effect and is useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by Aβ and typified by Alzheimer- type dementia.

7-Substituted Purine Derivatives for Immunosuppression

The present invention provides novel purinone and related derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula III: